DRREDDY vs NTPC: Stock Comparison
NTPC is the larger company by market capitalisation. DR. REDDY S LABORATORIES shows lower leverage and a higher ROCE, while NTPC shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
DRREDDY leads 6; NTPC leads 7 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | DRREDDY | NTPC |
|---|---|---|
| Sector | Healthcare | Power |
| Industry | Pharmaceuticals | Power Generation |
Price
| Metric | DRREDDY | NTPC |
|---|---|---|
| Live Price | ₹1,222.7 | ₹292.35 |
| Day Change | -1.32% | -3.39% |
| Volume | 8.2 L | 61.19 L |
| 52-Week High | ₹1,414.9 | ₹414.4 |
| 52-Week Low | ₹1,101 | ₹297.55 |
| Distance from 52W High | -13.58% | -29.45% |
Valuation
| Metric | DRREDDY | NTPC |
|---|---|---|
| Market Cap | ₹1.02 L Cr | ₹2.84 L Cr |
| P/E Ratio | 32.09x | 10.54x |
| P/B Ratio | 2.73x | 1.44x |
| EPS | ₹39.74 | ₹28.63 |
| Book Value | ₹460.31 | ₹209.44 |
| Dividend Yield | 0.64% | 2.97% |
Growth
| Metric | DRREDDY | NTPC |
|---|---|---|
| Revenue Growth (TTM YoY) | -11.6% | 8% |
| EPS Growth (TTM YoY) | -86.2% | -1.6% |
| Qtr Sales Growth | 7.33% | 0% |
| Qtr Profit Growth | 96.84% | 0% |
Profitability & Leverage
| Metric | DRREDDY | NTPC |
|---|---|---|
| ROE | 10.27% | 13.05% |
| ROCE | 12.07% | 8.01% |
| Net Margin | 12.76% | 15.38% |
| Operating Margin | 21.43% | 20.32% |
| Debt to Equity | 0.17x | 1.27x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | DRREDDY | NTPC |
|---|---|---|
| Promoter Holding | 26.64%▲ 0.01 pp | 51.1% |
| FII Holding | 32.07%▼ 1.01 pp | 15.79%▼ 0.51 pp |
| DII Holding | 31.74%▲ 1.02 pp | 29.87%▲ 0.43 pp |
| Public Holding | 9.35%▲ 0.02 pp | 3.24%▲ 0.09 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: DR. REDDY S LABORATORIES and NTPC.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.